05-Jan-2022
OXURION to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
OXURION to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Leuven, BELGIUM, Boston, MA, US – January 4, 2022 – 06.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will present and meet with investors at the H.C. Wainwright BioConnect 2022 Virtual Conference:
· H.C. Wainwright BioConnect 2022 Virtual Conference
January 10-13, 2022
Pre-recorded CEO Presentation available starting on January 10 at 7:00 AM ET
For more information, please visit Oxurion’s events page:
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
Last Updated: 05-Jan-2022
